Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Net sales $ 84,300 $ 364,182
Cost of sales 1,747,975 1,397,606
Gross loss (1,663,675) (1,033,424)
Operating expenses    
Selling, general and administrative 5,565,787 2,090,890
Research and development 1,902,236 1,362,275
Total operating expenses 7,468,023 3,453,165
Other income 864,900 0
Loss from operations (8,266,798) (4,486,589)
Interest (income) expense, net (13,023,489)  
Interest (income) expense, net   1,777,583
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total 4,756,691 (6,264,172)
Provision for income taxes 0 0
Net income (loss) $ 4,756,691 $ (6,264,172)
Net income (loss) attributable to common stockholders per share - basic (in usd per share) $ 0.07 $ (0.11)
Net income (loss) attributable to common stockholders per share - diluted (in usd per share) $ 0.06 $ (0.11)
Weighted average shares outstanding, basic (in shares) 68,465,759 55,260,519
Weighted average shares outstanding, diluted (in shares) 83,768,820 55,260,519